Summary
In the past 30 years, hepatitis C virus therapy has progressed from toxic regimens with low efficacy that included injectable IFN-alfa to the present highly effective interferon-free oral regimens with low toxicity. Implementation of risk reduction policies and national control strategies is needed to eradicate hepatitis C virus.
- hepatitis C virus
- interferon-free strategies
- HCV genotypes
- direct-acting antiviral drugs
- screening
- epidemiology
- global control
- HCV eradication
- emerging therapies
- infectious diseases screening & prevention
- viral infections
- © 2015 SAGE Publications
Tools
Table of contents
Cited By...
- No citing articles found.